Hostname: page-component-7b7567c8c-wxvwp Total loading time: 0 Render date: 2026-11-16T18:54:11.551Z Has data issue: false hasContentIssue false

Sex Selection by Preimplantation Genetic Diagnosis (PGD) for Nonmedical Reasons in Contemporary Israeli Regulations

Published online by Cambridge University Press:  21 May 2008

RICHARD V. GRAZI
Affiliation:
Division of Reproductive Endocrinology and Infertility at Maimonides Medical Center, Brooklyn, New York, and Genesis Fertility & Reproductive Medicine
JOEL B. WOLOWELSKY
Affiliation:
Yeshivah of Flatbush, Brooklyn, New York
DAVID J. KRIEGER
Affiliation:
Recanati School of Health Professionals at the Ben Gurion University of the Negev, Beer Sheva, Israel
Rights & Permissions [Opens in a new window]

Extract

We report here on recent developments in Israel on the issue of sex selection for nonmedical reasons by preimplantation genetic diagnosis (PGD). Sex selection for medical reasons (such as in cases of sex-linked genetic diseases) is generally viewed as uncontroversial and legal in European and American law. Its use for nonmedical reasons (like “balancing” the gender ratio in a family) is generally illegal in European countries. In the United States, it is not illegal, although in the opinion of the Ethics Committee of the American Society for Reproductive Medicine (ASRM), it is problematic. This position is undergoing reconsideration, albeit in a limited way.

Information

Type
Special Section: International Voices 2008
Copyright
Copyright © Cambridge University Press 2008